Kiora Pharmaceuticals Inc (KPRX) shareholders
Close on Nov 13, 2026Market cap $5.44MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Rockledge Capital Corporation Joint filing with Lincoln Park Capital Fund, LLC (9.99%), Lincoln Park Capital, LLC (9.99%) and 3 more | 768,155 | 9.99% | 13G (passive) amendment | Dec 31, 2023 |
| Rosalind Master Fund L.P. Joint filing with Rosalind Advisors, Inc. (9.90%), Salamon Steven A J (9.90%) and 1 more | 715,231 | 9.90% | 13G (passive) amendment | Dec 31, 2024 |
| Nantahala Capital Management, LLC Joint filing with Wilmot B. Harkey (9.99%), Daniel Mack (9.99%) | 491,889 | 9.99% | 13G (passive) amendment | Jun 30, 2026 |
| ADAR1 Capital Management GP, LLC Joint filing with ADAR1 Capital Management, LLC (9.90%), Daniel Schneeberger (9.90%) | 475,378 | 9.90% | 13G (passive) amendment | Jun 30, 2026 |
| Salamon Steven A J Joint filing with Rosalind Advisors, Inc. (9.90%), Aharon Gil (9.90%) and 1 more | 464,676 | 9.90% | 13G (passive) amendment | Dec 31, 2025 |
| Aharon Gil Joint filing with Rosalind Advisors, Inc. (9.90%), Salamon Steven A J (9.90%) and 1 more | 464,676 | 9.90% | 13G (passive) amendment | Jun 30, 2025 |
| Joseph Edelman Joint filing with Perceptive Advisors LLC (9.99%), Perceptive Life Sciences Master Fund, Ltd. (9.99%) | 442,387 | 9.99% | 13G (passive) | Apr 6, 2026 |
| Wilmot B. Harkey Joint filing with Nantahala Capital Management, LLC (9.99%), Daniel Mack (9.99%) | 438,469 | 9.99% | 13G (passive) amendment | Mar 31, 2026 |
| Alyeska Fund GP, LLC Joint filing with Alyeska Investment Group, L.P. (9.99%), Anand Parekh (9.99%) | 394,668 | 9.99% | 13G (passive) | Mar 31, 2026 |
| Stonepine Capital, L.P. Joint filing with Stonepine Capital Management, LLC (9.99%), Stonepine GP, LLC (9.99%) and 1 more | 307,229 | 9.99% | 13G (passive) amendment | Sep 30, 2024 |
| David Paolella Joint filing with Baselake Partners, LP (5.80%), Baselake Management, LLC (5.80%) | 257,500 | 5.80% | 13G (passive) | Sep 10, 2026 |
| Orin Hirschman Joint filing with AIGH Capital Management LLC (8.50%) | 255,555 | 8.50% | 13G (passive) amendment | Dec 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of KPRX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 438,471 | – | $1.15M | New | 0.02% |
| ADAR1 Capital Management, LLC | 167,941 | – | $441.69K | – | 0.02% |
| Citadel Advisors LLC | 116,011 | – | $305.11K | +66,478 | 0.00% |
| Two Sigma Investments, LP | 88,792 | – | $233.52K | New | 0.00% |
| Millennium Management LLC | 74,202 | – | $195.15K | New | 0.00% |
| Hrt Financial LP | 58,612 | – | $154.00K | New | 0.00% |
| Renaissance Technologies LLC | 29,824 | – | $78.44K | New | 0.00% |
| Geode Capital Management, LLC | 26,717 | – | $70.26K | −21,133 | 0.00% |
| Vanguard Capital Management LLC | 19,861 | – | $52.23K | – | 0.00% |
| Scientech Research LLC | 18,746 | – | $49.30K | New | 0.04% |
| Vanguard Fiduciary Trust Co | 13,030 | – | $34.27K | – | 0.00% |
| LPL Financial LLC | 12,500 | – | $32.88K | New | 0.00% |
| Dimensional Fund Advisors LP | 12,138 | – | $31.92K | New | 0.00% |
| Northern Trust Corp | 11,767 | – | $30.95K | New | 0.00% |
| Jane Street Group, LLC | 10,615 | – | $27.92K | New | 0.00% |
| UBS Group AG | 1,961 | – | $5.16K | +660 | 0.00% |
| Caitong International Asset Management Co., Ltd | 1,813 | – | $4.77K | +1,807 | 0.00% |
| Morgan Stanley | 1,408 | – | $3.70K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 837 | – | $2.20K | −158 | 0.00% |
| SBI Securities Co., Ltd. | 256 | – | $673 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 22 | 1M | 10 / 3 | 2 / 6 | 1M | 0M |
| Q1 2026 | 18 | 0M | 7 / 4 | 1 / 7 | 0M | 0M |
| Q4 2025 | 19 | 1M | 4 / 5 | 4 / 2 | 0M | 0M |
| Q3 2025 | 17 | 1M | 5 / 4 | 3 / 4 | 0M | 0M |
| Q2 2025 | 16 | 1M | 2 / 3 | 4 / 4 | 0M | 0M |
| Q1 2025 | 18 | 1M | 3 / 3 | 5 / 1 | 0M | 0M |
| Q4 2024 | 16 | 1M | 2 / 2 | 5 / 4 | 0M | 0M |
| Q3 2024 | 18 | 1M | 6 / 3 | 4 / 2 | 0M | 0M |
| Q2 2024 | 15 | 1M | 15 / 0 | 0 / 0 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
5 funds held KPRX in Q3 2026, 42% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of KPRX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 35,972 | – | $96.40K | 0.00% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 19,861 | – | $52.23K | 0.00% | Jun 30, 2026 |
| U.S. Vector Equity Portfolio | 3,923 | – | $10.28K | 0.00% | Jul 31, 2026 |
| Dimensional U.S. Core Equity 2 ETF | 3,510 | – | $9.20K | 0.00% | Jul 31, 2026 |
| Fidelity Series Total Market Index Fund | 3,446 | – | $9.24K | 0.00% | May 31, 2026 |
| Omni Small-Cap Value Fund | 2,000 | – | $5.26K | 0.00% | Jun 30, 2026 |
| U.S. Sustainability Core 1 Portfolio | 1,895 | – | $4.96K | 0.00% | Jul 31, 2026 |
| Dimensional US Core Equity 1 ETF | 1,574 | – | $4.12K | 0.00% | Jul 31, 2026 |
| U.S. Social Core Equity 2 Portfolio | 1,236 | – | $3.24K | 0.00% | Jul 31, 2026 |
| Fidelity Total Market Index Fund | 747 | – | $2.00K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Brian M. Strem | President and CEO, Director | 58,823 | Jul 2, 2026 |
| Melissa Tosca | CFO | 26,064 | Jul 2, 2026 |
| Eric Joseph Daniels | Chief Development Officer | 31,741 | Apr 2, 2026 |
| Lisa Walters-Hoffert | Director | 1,250 | Jun 12, 2026 |
| Aron Shapiro | Director | 3,000 | Jun 12, 2026 |
| Erin Parsons | Director | 5,260 | Jun 12, 2026 |
| Carmine N. Stengone | Director | 1,250 | Jun 12, 2026 |
| Praveen Tyle | Director | 5,014 | Jun 12, 2026 |
| David Hollander | Director | – | Jun 12, 2026 |
| Keith J. Lane | – | – | Sep 17, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Brian M. Strem President and CEO, Director | Jul 1, 2026 | Tax withholding | −1,869 | $2.66 | $4.97K | 58,823 |
| Melissa Tosca CFO | Jul 1, 2026 | Tax withholding | −911 | $2.66 | $2.42K | 26,064 |
| Melissa Tosca CFO | Apr 1, 2026 | Tax withholding | −929 | $1.95 | $1.81K | 26,975 |
| Brian M. Strem President and CEO, Director | Apr 1, 2026 | Tax withholding | −1,906 | $1.95 | $3.72K | 60,692 |
| Eric Joseph Daniels Chief Development Officer | Apr 1, 2026 | Tax withholding | −929 | $1.95 | $1.81K | 31,741 |
| Brian M. Strem President and CEO, Director | Mar 6, 2026 | Award | +16,733 | – | – | 62,598 |
| Melissa Tosca CFO | Mar 6, 2026 | Award | +6,533 | – | – | 27,904 |
| Eric Joseph Daniels Chief Development Officer | Mar 6, 2026 | Award | +6,533 | – | – | 32,670 |
| Eric Joseph Daniels Chief Development Officer | Mar 3, 2026 | Tax withholding | −238 | $2.02 | $481 | 26,137 |
| Brian M. Strem President and CEO, Director | Mar 3, 2026 | Tax withholding | −238 | $2.02 | $481 | 45,865 |
| Eric Joseph Daniels Chief Development Officer | Apr 1, 2025 | Award | +7,772 | – | – | 26,375 |
| Melissa Tosca CFO | Apr 1, 2025 | Award | +7,772 | – | – | 21,371 |
| Brian M. Strem President and CEO, Director | Apr 1, 2025 | Award | +15,941 | – | – | 46,103 |
| Carmine N. Stengone Director | Sep 11, 2024 | Buy | +1,250 | $3.68 | $4.60K | 1,250 |
| Aron Shapiro Director | Sep 10, 2024 | Buy | +3,000 | $3.60 | $10.80K | 3,000 |
| Lisa Walters-Hoffert Director | Aug 19, 2024 | Buy | +1,250 | $3.86 | $4.83K | 1,250 |
| Praveen Tyle Director | Aug 19, 2024 | Buy | +5,000 | $3.96 | $19.80K | 5,014 |
| Melissa Tosca CFO | Aug 14, 2024 | Buy | +2,000 | $3.21 | $6.42K | 13,599 |
| Brian M. Strem President and CEO, Director | Jul 1, 2024 | Award | +15,629 | – | – | 30,160 |
| Melissa Tosca CFO | Jul 1, 2024 | Award | +7,620 | – | – | 11,599 |
| Eric Joseph Daniels Chief Development Officer | Jul 1, 2024 | Award | +7,355 | – | – | 18,577 |
| Eric Joseph Daniels Chief Development Officer | Jun 14, 2024 | Buy | +1,431 | $5.29 | $7.57K | 11,222 |
| Melissa Tosca EVP Finance | Jun 14, 2024 | Buy | +100 | $5.25 | $525 | 3,979 |
| Erin Parsons Director | Jun 13, 2024 | Buy | +5,260 | $4.88 | $25.67K | 5,260 |
| Brian M. Strem President and CEO, Director | Jun 13, 2024 | Buy | +3,000 | $5.00 | $15.00K | 14,531 |
| Eric Joseph Daniels Chief Development Officer | Sep 29, 2023 | Award | +62,500 | – | – | 88,338 |
| Melissa Tosca EVP Finance | Sep 29, 2023 | Award | +30,000 | – | – | 34,900 |
| Brian M. Strem President and CEO, Director | Sep 29, 2023 | Award | +75,000 | – | – | 103,783 |
| Eric Joseph Daniels Chief Development Officer | Mar 3, 2023 | Award | +15,600 | – | – | 25,838 |
| Melissa Tosca EVP Finance | Mar 3, 2023 | Award | +2,400 | – | – | 7,400 |
| Brian M. Strem President and CEO, Director | Mar 3, 2023 | Award | +15,600 | $3.83 | $59.75K | 28,783 |
| Melissa Tosca EVP of Finance | Oct 21, 2022 | Award | +2,500 | – | – | 2,500 |
| Brian M. Strem President and CEO, Director | Oct 21, 2022 | Award | +12,500 | – | – | 13,183 |
| Eric Joseph Daniels Chief Development Officer | Oct 21, 2022 | Award | +10,000 | – | – | 10,238 |
| Sarah Romano Chief Financial Officer | Feb 10, 2022 | Tax withholding | −108 | $0.69 | $75 | 22,746 |
| Sarah Romano Chief Financial Officer | Jan 5, 2022 | Tax withholding | −114 | $1.08 | $123 | 22,854 |
| Stephen From Executive Chairman, Director | Jan 5, 2022 | Tax withholding | −326 | $1.08 | $352 | 67,693 |
| Sarah Romano Chief Financial Officer | Dec 7, 2021 | Tax withholding | −91 | $1.30 | $118 | 22,968 |
| Stephen From Executive Chairman, Director | Dec 7, 2021 | Tax withholding | −273 | $1.30 | $355 | 68,019 |
| Brian M. Strem President and CEO, Director | Nov 18, 2021 | Buy | +17,853 | $1.41 | $25.17K | 27,370 |
| Stephen From Executive Chairman, Director | Nov 2, 2021 | Tax withholding | −250 | $1.98 | $495 | 68,292 |
| Brenda Mann VP of Research & Development | Nov 2, 2021 | Tax withholding | −62 | $1.98 | $123 | 15,136 |
| Sarah Romano Chief Financial Officer | Nov 2, 2021 | Tax withholding | −83 | $1.98 | $164 | 23,059 |
| Brian M. Strem President and CEO, Director | Oct 21, 2021 | Award | +9,517 | – | – | 9,517 |
| Eric Joseph Daniels Chief Development Officer | Oct 21, 2021 | Award | +9,520 | – | – | 9,520 |
| Sarah Romano Chief Financial Officer | Oct 4, 2021 | Tax withholding | −83 | $2.01 | $167 | 23,142 |
| Stephen From Executive Chairman, Director | Oct 4, 2021 | Tax withholding | −249 | $2.01 | $500 | 68,542 |
| Brenda Mann VP of Research & Development | Oct 4, 2021 | Tax withholding | −62 | $2.01 | $125 | 15,198 |
| Sarah Romano Chief Financial Officer | Sep 2, 2021 | Tax withholding | −84 | $1.81 | $152 | 23,225 |
| Brenda Mann VP of Research & Development | Sep 2, 2021 | Tax withholding | −61 | $1.81 | $110 | 15,260 |
| Stephen From Executive Chairman, Director | Sep 2, 2021 | Tax withholding | −253 | $1.81 | $458 | 68,791 |
| Stephen From Executive Chairman, Director | Aug 3, 2021 | Tax withholding | −261 | $2.40 | $626 | 69,044 |
| Sarah Romano Chief Financial Officer | Aug 3, 2021 | Tax withholding | −87 | $2.40 | $209 | 23,309 |
| Michael P. Manzo VP of Engineering | Aug 3, 2021 | Tax withholding | −65 | $2.40 | $156 | 15,378 |
| Brenda Mann VP of Research & Development | Aug 3, 2021 | Tax withholding | −63 | $2.40 | $151 | 15,321 |
| Armistice Capital, Llc 10% owner | Aug 2, 2021 | Sale | −192,775 | $2.40 | $462.66K | 785,000 |
| Armistice Capital, Llc 10% owner | Jul 30, 2021 | Sale | −68,188 | $2.69 | $183.43K | 977,775 |
| Steven Boyd Director, 10% owner | Jul 29, 2021 | Sale | −400,000 | $3.00 | $1.20M | 1,045,963 |
| Steven Boyd Director, 10% owner | Jul 28, 2021 | Sale | −375,443 | $3.28 | $1.23M | 1,445,963 |
| Steven Boyd Director, 10% owner | Jul 27, 2021 | Conversion | +852,500 | $4.80 | $4.09M | 4,199,101 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Kiora Pharmaceuticals's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?